News

Life Sciences

Q BioMed Partners with SRI to Develop Pediatric Developmental Nonverbal Disorder Therapy

Spotlight Companies | Equities.com |

Part of Q BioMed's autistic spectrum disorder drug development program (Image: Autism Speaks)


BioLineRx Begins Triple Combination Arm of Phase 2a Pancreatic Cancer Trial

Edward Kim | Equities.com |

BL-8040 + Keytruda + chemotherapy combination in metastatic pancreatic cancer (Image: BioLineRx)


CollPlant Announces Positive Clinical Data Published for Tennis Elbow Treatment

Edward Kim | Equities.com |

59% improvement in chronic tennis elbow at 6 months after treatment with recombinant human collagen for soft tissue repair.


DiaMedica Therapeutics Raises $16 Million and Uplists to Nasdaq

Edward Kim | Equities.com |

Lead compound targeting acute ischemic stroke and chronic kidney disease (Image: DiaMedica Therapeutics).


Premier Biomedical Expands Distribution Network for CBD / Hemp Oil Pain Relievers

Edward Kim | Equities.com |

Keep an eye on the 2018 Farm Bill, which may get a vote in Congress next week.


​Biotech in 2019: Gene Therapies, Cancer Immunotherapies, and mRNA

Guild Investment Management | Equities.com |

Investing in early-stage biotechnology companies requires great skill and patience (luck is always helpful as well).


PetVivo: Microcap Play in $18 Billion Veterinary Care Market

Edward Kim | Equities.com |

Lead product for osteoarthritis in dogs and lameness from navicular disease in horses (Image: PetVivo).


Generex Acquires Majority Stake in Olaregen Therapeutix to Enter Wound Healing Market

Edward Kim | Equities.com |

Olaregen's Excellagen (flowable dermal matrix) is FDA approved for wound management in multiple indications (Image: Olaregen Therapeutix)


X4 Pharmaceuticals to Become Public via Reverse Merger with Arsanis

Edward Kim | Equities.com |

Phase 3 trial for X4's lead candidate anticipated to start in the first half of 2019 in WHIM syndrome (Image: X4 Pharmaceuticals).


Applied DNA's SigNature Anti-Theft Molecular Tags Lead to Successful Criminal Convictions

Edward Kim | Equities.com |

Over 131 convictions, with sentences of 625 years to date and more cases in the pipeline (Image: Applied DNA Sciences).


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Dr. Martin Eaton - Heads Up Checkup

Equities.com Host & Contributor Silvia Davi interviewing CEO of Heads Up Checkup, Dr. Martin Eaton.